Division of Hematology-Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Center for Cancer and Blood Disorders, Children's Medical Center, Dallas, TX 75390-9063 , USA.
Semin Hematol. 2013 Jan;50 Suppl 1:S26-30. doi: 10.1053/j.seminhematol.2013.03.006.
Assessing clinical bleeding in patients with immune thrombocytopenia (ITP) and predicting future risk of major hemorrhage has proven to be a complicated task given the heterogeneity in bleeding manifestations. Although bleeding scales have been used for this purpose, they fail to account for occult or subclinical hemorrhage. Little is known about the frequency and clinical significance of occult hemorrhage in ITP and no formal investigations have been published on the subject. However, determining the prevalence and incidence of occult hemorrhage may shed light on our understanding of bleeding severity in both children and adults. This review explores the potential clinical significance, sites and methods of testing of subclinical microbleeding in ITP.
评估免疫性血小板减少症 (ITP) 患者的临床出血情况并预测未来发生大出血的风险,鉴于出血表现的异质性,这被证明是一项复杂的任务。尽管已经使用了出血量表,但它们无法说明隐匿性或亚临床性出血。关于 ITP 中隐匿性出血的频率和临床意义知之甚少,也没有关于该主题的正式研究发表。然而,确定隐匿性出血的患病率和发生率可能有助于我们了解儿童和成人的出血严重程度。本综述探讨了 ITP 中亚临床微出血的潜在临床意义、检测部位和方法。